Saturday 17 October 2026
Export SNN’s income statement to Excel — free account
Smith & Nephew SNATS, Inc.
SNN Healthcare Medical Devices
Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024. Revenue growth for five consecutive years, operating cash flow growth for three.
29.06
0.03
−0.10%
Follow SNN
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
1.11 | 1.25 | 1.40 | 1.33 | |
Current Ratio |
2.14 | 2.57 | 3.00 | 2.89 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
29.17% | 30.38% | 30.84% | 31.47% | |
Debt/Equity |
0.62 | 0.60 | 0.60 | 0.62 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.63) | (0.69) | (0.47) | (0.59) | |
Intangible Assets out of Total Assets |
0.39 | 0.38 | 0.38 | 0.39 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Free Cash Flow Yield |
— | — | — | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
260.00 | 890.00 | 269.00 | 606.00 | |
Working Capital |
2,336.00 | 2,508.00 | 3,086.00 | 2,890.00 | |
Capital Expenditures |
(190.00) | (395.00) | (127.00) | (381.00) | |
Net Current Asset Value |
(1,446.00) | (1,065.00) | (529.00) | (668.00) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1,459.50 | 1,381.00 | 1,380.50 | 1,358.00 | |
Average Payables |
1,136.50 | 1,116.00 | 1,026.00 | 1,113.00 | |
Average Inventory |
2,302.00 | 2,256.00 | 2,439.00 | 2,296.00 | |
Average Assets |
10,777.50 | 10,222.00 | 10,268.00 | 10,160.00 | |
Average Common Equity |
5,192.50 | 5,253.00 | 5,384.50 | 5,262.00 |
Columns are period end dates